JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹292 Cr | ₹225 Cr | ₹203 Cr | ₹171 Cr | ₹164 Cr |
What is the latest Total Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹292 Cr |
| Mar2024 | ₹225 Cr |
| Mar2023 | ₹203 Cr |
| Mar2022 | ₹171 Cr |
| Mar2021 | ₹164 Cr |
How is Total Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹292 Cr | 29.91 | |
| Mar2024 | ₹225 Cr | 10.90 | |
| Mar2023 | ₹203 Cr | 18.18 | |
| Mar2022 | ₹171 Cr | 4.38 | |
| Mar2021 | ₹164 Cr | - | |
Compare Total Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,159.0 Cr | 2.4% | -8.9% | -28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 2.4% |
-8.9% |
-28.3% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses